Correlation Between Gensight Biologics and VOGO SA
Can any of the company-specific risk be diversified away by investing in both Gensight Biologics and VOGO SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gensight Biologics and VOGO SA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gensight Biologics SA and VOGO SA, you can compare the effects of market volatilities on Gensight Biologics and VOGO SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gensight Biologics with a short position of VOGO SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gensight Biologics and VOGO SA.
Diversification Opportunities for Gensight Biologics and VOGO SA
0.43 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Gensight and VOGO is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Gensight Biologics SA and VOGO SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VOGO SA and Gensight Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gensight Biologics SA are associated (or correlated) with VOGO SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VOGO SA has no effect on the direction of Gensight Biologics i.e., Gensight Biologics and VOGO SA go up and down completely randomly.
Pair Corralation between Gensight Biologics and VOGO SA
Assuming the 90 days trading horizon Gensight Biologics SA is expected to generate 1.89 times more return on investment than VOGO SA. However, Gensight Biologics is 1.89 times more volatile than VOGO SA. It trades about 0.01 of its potential returns per unit of risk. VOGO SA is currently generating about -0.03 per unit of risk. If you would invest 30.00 in Gensight Biologics SA on September 30, 2024 and sell it today you would lose (2.00) from holding Gensight Biologics SA or give up 6.67% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Gensight Biologics SA vs. VOGO SA
Performance |
Timeline |
Gensight Biologics |
VOGO SA |
Gensight Biologics and VOGO SA Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Gensight Biologics and VOGO SA
The main advantage of trading using opposite Gensight Biologics and VOGO SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gensight Biologics position performs unexpectedly, VOGO SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VOGO SA will offset losses from the drop in VOGO SA's long position.Gensight Biologics vs. DBV Technologies SA | Gensight Biologics vs. Inventiva SA | Gensight Biologics vs. Quantum Genomics SA | Gensight Biologics vs. Abivax SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |